These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33644864)

  • 1. Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.
    Ordóñez-Rubiano MF; Rubiano-Mojica PC; Casas M
    Int J Dermatol; 2021 Apr; 60(4):514-515. PubMed ID: 33644864
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 3. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 4. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
    Dobkin H; Mullen R; Zirwas M
    Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
    [No Abstract]   [Full Text] [Related]  

  • 5. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract]   [Full Text] [Related]  

  • 6. Safe and effective treatment of atopic dermatitis using dupilumab over 23 months in a patient with HIV.
    Lor M; Villa N; Holland V
    Dermatol Ther; 2020 Nov; 33(6):e14271. PubMed ID: 32882092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up.
    Romagnuolo M; Angileri L; Tavecchio S; Marzano AV; Ferrucci S
    Clin Exp Dermatol; 2020 Aug; 45(6):762-763. PubMed ID: 32379943
    [No Abstract]   [Full Text] [Related]  

  • 9. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 10. Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients.
    Ordóñez-Rubiano MF; Campo I; Casas M
    Dermatol Ther; 2020 Nov; 33(6):e14172. PubMed ID: 32779378
    [No Abstract]   [Full Text] [Related]  

  • 11. Dupilumab may facilitate the clearance of molluscum contagiosum in atopic dermatitis patients.
    Di Lernia V; Casanova DM; Simonetti V
    J Dtsch Dermatol Ges; 2020 Sep; 18(9):1016-1018. PubMed ID: 32881369
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency.
    Tanner JF; Knutsen AP; Siegfried E
    Dermatitis; 2021 Oct; 32(1S):e91-e92. PubMed ID: 34677168
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe Adult Atopic Dermatitis: Clinical Challenges.
    Russo F; Flori ML; Gola M; Milanesi N
    Dermatitis; 2020; 31(4):e48-e49. PubMed ID: 32209869
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto.
    Georgakopoulos JR; Yeung J
    J Cutan Med Surg; 2020; 24(4):422-423. PubMed ID: 32434413
    [No Abstract]   [Full Text] [Related]  

  • 16. Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series.
    Bosma AL; Gerbens LAA; Middelkamp-Hup MA; Spuls PI
    Clin Exp Dermatol; 2021 Aug; 46(6):1089-1092. PubMed ID: 33969522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina].
    Máspero J; Angles MV; Ardusso L; Brancciforte M; Castro C; Cruz Iturrieta C; Chouela E; De Gennaro MS; Fernández Bussy R; Galimberti ML; Galimberti RL; Gattolin G; Luna PC; Magariños G; Marini MG; Maskin M; Plafnik R; Raimondo N; Russo JP; Sevinsky L; Stringa MF
    Rev Fac Cien Med Univ Nac Cordoba; 2020 Jun; 77(2):94-99. PubMed ID: 32558511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series.
    Amoedo P; Rosa G; Baudrier T; Pedrosa AF; Cruz MJ
    An Bras Dermatol; 2024; 99(5):721-724. PubMed ID: 38834396
    [No Abstract]   [Full Text] [Related]  

  • 20. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS.
    Silverberg JI; Yosipovitch G; Simpson EL; Kim BS; Wu JJ; Eckert L; Guillemin I; Chen Z; Ardeleanu M; Bansal A; Kaur M; Rossi AB; Graham NMH; Patel N; Gadkari A
    J Am Acad Dermatol; 2020 Jun; 82(6):1328-1336. PubMed ID: 32135208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.